Related references
Note: Only part of the references are listed.Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat
Ying-Ying Yang et al.
LIVER INTERNATIONAL (2014)
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Stephanie Coulon et al.
CYTOKINE (2012)
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Anabela P. Rolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Understanding the Mechanism of Hepatic Fibrosis and Potential Therapeutic Approaches
Areeba Ahmad et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
Martin Hennenberg et al.
LABORATORY INVESTIGATION (2011)
Mitochondrial dysfunction in nonalcoholic steatohepatitis
Gaetano Serviddio et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Subir Kumar Das et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2011)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Severe liver steatosis correlates with nitrosative and oxidative stress in rats
I. Grattagliano et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma
Vicencia M. R. de Lima et al.
JOURNAL OF HEPATOLOGY (2008)
Mitochondrial involvement in non-alcoholic steatohepatitis
Gaetano Serviddio et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of mitochondria in non-alcoholic fatty liver disease
Dominique Pessayre
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
Stefanie Hemmann et al.
JOURNAL OF HEPATOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mechanisms of fibrolysis in chronic liver injury (with special emphasis on MMPs and TIMPs)
M. Roderfeld et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2007)
Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice
Martin Roderfeld et al.
FASEB JOURNAL (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease
CPMS Oliveira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Liver fibrogenesis: A new role for the renin-angiotensin system
R Bataller et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis
E Ueberham et al.
HEPATOLOGY (2003)
Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice
FG Soriano et al.
SHOCK (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
